Literature DB >> 33672234

Accidental Consumption of Aspartame in Phenylketonuria: Patient Experiences.

Ella Newbould1, Alex Pinto2, Sharon Evans2, Suzanne Ford3, Mike O'Driscoll4, Catherine Ashmore2, Anne Daly2, Anita MacDonald2.   

Abstract

Aspartame is a phenylalanine containing sweetener, added to foods and drinks, which is avoided in phenylketonuria (PKU). However, the amount of phenylalanine provided by aspartame is unidentifiable from food and drinks labels. We performed a cross-sectional online survey aiming to examine the accidental aspartame consumption in PKU. 206 questionnaires (58% female) were completed. 55% of respondents (n = 114) were adults with PKU or their parent/carers and 45% (n = 92) were parents/carers of children with PKU. 74% (n = 152/206) had consumed food/drinks containing aspartame. Repeated accidental aspartame consumption was common and more frequent in children (p < 0.0001). The aspartame containing food/drinks accidentally consumed were fizzy drinks (68%, n = 103/152), fruit squash (40%, n = 61/152), chewing gum (30%, n = 46/152), flavoured water (25%, n = 38/152), ready to drink fruit squash cartons (23%, n = 35/152) and sports drinks (21%, n = 32/152). The main reasons described for accidental consumption, were manufacturers' changing recipes (81%, n = 123/152), inability to check the ingredients in pubs/restaurants/vending machines (59%, n = 89/152) or forgetting to check the label (32%, n = 49/152). 23% (n= 48/206) had been prescribed medicines containing aspartame and 75% (n = 36/48) said that medicines were not checked by medics when prescribed. 85% (n = 164/192) considered the sugar tax made accidental aspartame consumption more likely. Some of the difficulties for patients were aspartame identification in drinks consumed in restaurants, pubs, vending machines (77%, n = 158/206); similarities in appearance of aspartame and non-aspartame products (62%, n = 127/206); time consuming shopping/checking labels (56%, n = 115/206); and unclear labelling (55%, n = 114/206). These issues caused anxiety for the person with PKU (52%, n = 106/206), anxiety for parent/caregivers (46%, n = 95/206), guilt for parent/carers (42%, n = 87/206) and social isolation (42%, n = 87/206). It is important to understand the impact of aspartame and legislation such as the sugar tax on people with PKU. Policy makers and industry should ensure that the quality of life of people with rare conditions such as PKU is not compromised through their action.

Entities:  

Keywords:  aspartame; phenylalanine; phenylketonuria; sugar tax

Mesh:

Substances:

Year:  2021        PMID: 33672234      PMCID: PMC7926728          DOI: 10.3390/nu13020707

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  14 in total

Review 1.  The world market for intense sweeteners.

Authors:  J Fry
Journal:  World Rev Nutr Diet       Date:  1999       Impact factor: 0.575

2.  Aspartame loading test in PKU heterozygous individuals bearing severe and moderate mutations.

Authors:  L C da Silva; T S Carvalho; F B da Silva; R F Pires; R Giugliani; M L Pereira
Journal:  Clin Genet       Date:  2000-07       Impact factor: 4.438

3.  Food Additives Permitted for Direct Addition to Food for Human Consumption; Folic Acid. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2016-04-15

4.  Aspartame and Risk of Cancer: A Meta-analytic Review.

Authors:  Sreekanth Mallikarjun; Rebecca McNeill Sieburth
Journal:  Arch Environ Occup Health       Date:  2015       Impact factor: 1.663

5.  Don't scrap the sugar tax, doctors tell Johnson.

Authors:  Abi Rimmer
Journal:  BMJ       Date:  2019-12-19

6.  Plasma phenylalanine levels in phenylketonuric heterozygous and normal adults administered aspartame at 34 mg/kg body weight.

Authors:  L D Stegink; R Koch; M E Blaskovics; L J Filer; G L Baker; J E McDonnell
Journal:  Toxicology       Date:  1981       Impact factor: 4.221

7.  Effect of an abuse dose of aspartame upon plasma and erythrocyte levels of amino acids in phenylketonuric heterozygous and normal adults.

Authors:  L D Stegink; L J Filer; G L Baker; J E McDonnell
Journal:  J Nutr       Date:  1980-11       Impact factor: 4.798

Review 8.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

9.  Aspartame and Phe-Containing Degradation Products in Soft Drinks across Europe.

Authors:  Kimber van Vliet; Elise S Melis; Pim de Blaauw; Esther van Dam; Ronald G H J Maatman; David Abeln; Francjan J van Spronsen; M Rebecca Heiner-Fokkema
Journal:  Nutrients       Date:  2020-06-24       Impact factor: 5.717

Review 10.  PKU dietary handbook to accompany PKU guidelines.

Authors:  A MacDonald; A M J van Wegberg; K Ahring; S Beblo; A Bélanger-Quintana; A Burlina; J Campistol; T Coşkun; F Feillet; M Giżewska; S C Huijbregts; V Leuzzi; F Maillot; A C Muntau; J C Rocha; C Romani; F Trefz; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2020-06-30       Impact factor: 4.123

View more
  3 in total

1.  Efficacy of a New Low-Protein Multimedia Diet App for PKU.

Authors:  Sharon Evans; Catherine Ashmore; Anne Daly; Perninder Dhadwar; Atif Syed; Olivia Lecocq; Richard Jackson; Alex Pinto; Anita MacDonald
Journal:  Nutrients       Date:  2022-05-24       Impact factor: 6.706

2.  The Challenges and Dilemmas of Interpreting Protein Labelling of Prepackaged Foods Encountered by the PKU Community.

Authors:  Imogen Hall; Alex Pinto; Sharon Evans; Anne Daly; Catherine Ashmore; Suzanne Ford; Sharon Buckley; Anita MacDonald
Journal:  Nutrients       Date:  2022-03-24       Impact factor: 5.717

Review 3.  Aspartame-True or False? Narrative Review of Safety Analysis of General Use in Products.

Authors:  Kamila Czarnecka; Aleksandra Pilarz; Aleksandra Rogut; Patryk Maj; Joanna Szymańska; Łukasz Olejnik; Paweł Szymański
Journal:  Nutrients       Date:  2021-06-07       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.